Objective-Porosity of the intraluminal thrombus (ILT) is believed to convey biologically active components from the bloodstream toward the aneurismal wall. Accumulation of molecules in the abdominal aortic aneurysmatic tissue may influence vascular protein turnover and regulate abdominal aortic aneurysm growth. We sought to identify proteins with concentrations in the ILT and the abdominal aortic aneurysm wall which associate with aneurysmal expansion rate. Approach and Results-Proteomic analysis by liquid chromatography tandem-mass spectrometry of separated wall and ILT samples was correlated with preoperative aneurysmal growth rate in 24 individuals operated electively for infrarenal abdominal aortic aneurysm. The median preoperative growth rate was 3.8 mm/y (interquartile range, 3) and the mean observational time was 3.3±1.7 years. Plasma components dominated the group of proteins with tissue concentrations, which correlate positively with growth rates (P<0.001, Fisher exact test, both in the ILT and the wall). In contrast, in the wall and thrombus samples, ECM (extracellular matrix) proteins were significantly more prevalent in the group of proteins with negative correlations to growth rates (P<0.05, Fisher exact test). Similarly, a long series of proteins, related to cellular functions correlated negatively to growth rates. Conclusions-When the preoperative aneurysmatic growth rate has been high, the concentration of many plasma proteins residing in the ILT and the aneurysmatic tissue is also high, compatible with the hypothesis of increased tissue porosity and accumulation of plasma components as a driver of aneurysm expansion. Moreover, many matrix and cellular proteins which are found in high concentrations in slower-growing aneurysms provides new knowledge about potential treatment targets. Visual Overview-An online visual overview is available for this article.
A n abdominal aortic aneurysm (AAA) is a potentially lifethreatening disease. The mean growth rate of an AAA is 2 to 3 mm/y, but growth rates may be prone to wider variation. 1 In healthy subjects, surgical repair is usually recommended if the anterior to posterior size exceeds 5.5 cm in men and 5.0 to 5.2 cm in women, 1 although the latter is still under debate. Faster-growing aneurysms may be more aggressive and may pose a greater risk. 1 A better understanding of the molecular determinants of the expansion rate is considered critical both in relation to identifying new possible treatment targets and for the development of relevant biomarkers for this disease.
Almost all AAAs reaching a certain size contain an intraluminal thrombus (ILT). 2 The formation of the ILT is not fully understood, but it seems to vary from patient to patient. 3 Some patients have large and probably old, layered thrombi; others more discrete fresh thrombi 4 ; however, the exact role of the ILT in the growth of AAAs remains unclear.
The ILT has been hypothesized to form part of a spatiotemporal model of atherothrombosis, 5 where biologically active substances are transported from the bloodstream toward the AAA wall. 5 This transport is believed to be caused by centripetal convection mediated by pores in the ILT to convey larger molecules, like plasma proteins, toward the AAA wall. 6, 7 Newer molecular imaging techniques also show uptake of 18 F-fludeoxyglucose and ultrasmall superparamagnetic particles of iron oxide into the ILT 8, 9 as a marker of cellular deposition, migration, and decomposition. 10 In finite elements simulations using computed tomography angiography scans from AAA patients, cracks and fissures in the ILT increase wall stress on the underlying AAA wall. 11 Differences in ILT composition may result in different quantities and compositions of biologically active proteins accumulating near and in the AAA wall. Likewise, it has been suggested that the sponginess of the arterial wall and its content of plasma and thrombus components may be part of an aneurysm's natural history, hereby determining its growth rate. 5 Not only the presence and the molecular composition of the thrombus, but also the molecular contents of the aneurysmatic arterial wall itself are believed to influence the expansion rate. A few proteome studies have been conducted on human arterial tissue from abdominal aneurysms and ILT. Most of these studies have used 2-dimensional gel electrophoresis and subsequent identification of a few proteins of potential interest. Only one study has focused on AAA-growth rates, 12 and most proteome studies of AAA and ILT samples have used pooled samples and included <15 individual samples. [13] [14] [15] No previous studies have attempted to use proteome analysis of separate samples from both the aneurismal wall and the corresponding thrombus; and previous results do therefore, to a large degree, reflect the ratio of ILT/wall of the analyzed material. In the present study, we use quantitative liquid chromatography tandem-mass spectrometry (LC-MS/MS) proteome analysis of samples extracted from separated AAA wall and thrombus specimens from a group of electively operated patients in whom the expansion rate had been determined in the years preceding their surgical intervention.
Our overall hypothesis is that the concentration of a series of specific proteins in both the wall and the thrombus may be associated with AAA expansion rates. We envision that the increased porosity of the arterial wall and the thrombus described above may be associated with accumulation of plasma proteins, that is, we expect that the AAA expansion rate is correlated with high concentrations of several plasma proteins both in material from the thrombus and in the arterial wall. Moreover, we suggest that considerable amounts of ECM (extracellular matrix) components and cytoskeletal proteins in the wall and ILT, as estimates of robustness of the arterial tissue and thrombus will correlate negatively with the AAA-growth rate. Likewise, we expect that high concentrations of proteins related to cellular functions, for example, protein synthesis and folding may be negatively correlated to AAA growth. Finally, we think that the determination of a list of proteins in both types of material where concentrations correlates with the AAA-growth rate may suggest important molecular pathophysiological pathways and display potential new treatment targets and biomarkers.
Materials and Methods
The authors declare that all supporting data are available within the article and in the online-only Data Supplement.
Patient Population
From April 2014 to March 2016, 46 samples were harvested from patients undergoing open AAA repair at the Department of Vascular Surgery, Viborg Regional Hospital, Viborg, Central Denmark Region, Denmark. Written consent was provided by all patients before their operation. The project was preapproved and preregistered by the Danish data protection authorities and the regional ethics committee (record no: 1-10-72-69-14). The patients were enrolled from the outpatient clinic and planned for elective open repair. Men as well as women were eligible for enrollment. Data were obtained from the Danish Electronic Medical Journal MidtEPJ, and from the VIVA 16 database if the patient was also enrolled there. The following information was collected from patient files or from parameters obtained for research purposes from individuals who also participated in the VIVA trial (The Viborg Vascular Trial): age, previous AAA in the family, current smoking, diabetes mellitus, hypertension, chronic obstructive pulmonary disease, peripheral arterial disease, previous acute myocardial infarction or ischemic heart disease, statin usage, and aspirin usage. The size of the abdominal aorta was measured along with the anterior to posterior inner-to-inner distance, which was measured with ultrasound at baseline and at every follow-up visit. In the VIVA study, the ultrasound hardware used was a General Electric Healthcare (Fairfield, CT) Logiq E with a 4 MHz abdominal probe. In the outpatient clinic, a Philips Healthcare (Best, The Netherlands) Matrix iU22 with a 4 MHz abdominal probe was used. The anterior to posterior measurement was performed at peak systole at the part of maximum dilatation. 17 In 1 patient case only, 2 repeated computed tomography angiography scans were available, and although a growth rate could have been calculated we choose to exclude this patient from the correlation analysis because of lack of evidence about ultrasound and computed tomography growth rate estimation.
The persons who performed the dissections and the biochemical analyses were blinded to all clinical data, including growth rate.
Sampling
The anterior part of the most dilated point of the AAA was chosen as the site to harvest the AAA-wall sample and the corresponding ILT. The operatively removed samples were immediately frozen at −20° and quickly relocated to a −80° storage facility until the time of proteomic analysis. The complete ILT was sampled (if possible) and the anterior part close to the corresponding wall section was marked either with a surgical clip or using a suture.
During thawing of the specimens, sampling for biochemical analysis was done at the same position for each specimen, that is, at the anterior wall section at the location with maximal dilatation, and if thrombus was present, it was collected from the same place as well. The person sampling tissue was unaware of growth rate status.
From 46 samples, 40 wall specimens and 24 ILT specimens could be used for individual proteome analysis and proteins were extracted from the samples and ultrasonicated as described below. Results from all samples are shown in Table II in the online-only Data Supplement, where information about growth rate is also present; however, because ultrasound determined growth rate is only present in a subset of samples; only results from this subset are presented in this article. Figure 1 demonstrates a simplified overview of the samples.
Preparation of Protein Samples for Proteome Analysis
Proteins were extracted by dissolving ≈10 mg of the collected thrombus wall or the thrombus in extraction buffer (200 mmol/L dithiothreitol, 50 mmol/L tetraethylammonium bicarbonate, and 2% sodium dodecyl sulfate) and subjecting the samples to 3 rounds of ultrasonication (15 minutes in an ultrasonication bath followed by 15 minutes of cooling). Subsequently, samples were incubated at 99°C for 20 minutes followed by incubation at 80°C for 120 minutes. Extracted proteins were alkylated by addition of a 600 mmol/L iodoacetamide solution to a final dithiothreitol:iodoacetamide concentration ratio of 1:3 for 30 minutes at room temperature in the dark. 
LC-MS/MS
liquid chromatography tandem-mass spectrometry peptides were isotopically labeled using the 10-plex tandem mass tag (ThermoFisher Scientific, Waltham, MA). Peptide samples from the wall and the thrombus were randomly labeled with the 127 N, 127C, 128 N, 128C, 129 N, 129C, and 130 N mass tags, whereas pools of the wall samples and the thrombus samples were labeled with the 126 and 130C mass tags that served as internal standards. Tagged peptides were mixed into 10 mixed peptide samples that were fractionated using hydrophilic interaction chromatography, as described below.
Hydrophilic Interaction Chromatography Fractionation
Samples were fractionated using hydrophilic interaction chromatography. Briefly, samples redissolved in 90% acetonitrile/0.1% trifluoric acid and 15 µL aliquots corresponding to ≈25 µg peptides were injected onto an in-house-packed TSK gel Amide-80 hydrophilic interaction chromatography 300 μm×300 mm capillary high-performance liquid chromatography column and fractionated into 11 fractions by a Dionex UltiMate 3000 nano high-performance liquid chromatography. Samples were loaded on-column at a flow rate of 12 µL/min for 6 minutes in a 90% solution B (100% acetonitrile/0.1% trifluoric acid) followed by a decrease in flow rate to 6 µL/min and to 85.5% solution B from the sixth minute to the ninth minute. Hereafter, a 24-minute linear gradient to 46% solution A (0.1% trifluoric acid) was used to separate the peptide mixtures into 11 fractions that were automatically collected in microwell plates at 2-minute intervals after ultraviolet detection at 210 nm. The fractions were dried by vacuum centrifugation and redissolved in 10 µL 0.1% trifluoric acid and analyzed by nano LC-MS/MS, as described below.
Nano LC-MS/MS
Nano LC-MS/MS analysis was conducted on a Q-Exactive mass spectrometer (Thermo Fisher Scientific, Bremen, Germany) equipped with a nano high-performance liquid chromatography interface (Dionex UltiMate 3000 nano high-performance liquid chromatography). All samples were analyzed both in a discovery experiment and in a subsequent validation/verification setup to verify some proteins by the identification of separate peptides. 18 The samples analyzed in the discovery experiment (tandem mass-tagged samples) and the validation experiments (label-free design) were both analyzed by the LC-MS/MS method described below. Briefly, samples (5 µL) were loaded onto a custom-made, fused capillary precolumn (2 cm length, 360 µm OD, 75 µm ID packed with ReproSil Pur C18 3 µm resin [Dr Maish, GmbH]) with a flow of 5 µL/min for 7 minutes. Trapped peptides were separated on a custom-made fused capillary column (20 cm length, 360 µm OD, 100 µm ID, packed with ReporSil Pur C13 3 µm resin) using a linear gradient from 95% solution A (0.1% formic acid) to 30% B (100% acetonitrile in 0.1% formic acid) >51 minutes followed by 5 minutes at 90% B and 5 minutes at 98% A at a flow rate of 300 nL per minute. Mass spectra were acquired in positive ion mode applying an automatic data-dependent switch between an Orbitrap survey MS scan in the mass range from 400 to 1200 m/z followed by high-energy collisional dissociation fragmentation and Orbitrap detection of the 15 (10 in the validation/verification experiment) most intense ions observed in the MS scan. The target value in the Orbitrap for MS scan was 1 000 000 ions at a resolution of 70 000 m/z 200 and 50 000 ions at a resolution of 35 000 (17 500 for the validation/verification experiment) at m/z 200 for MS/MS scans. Fragmentation of the peptides in the high-energy collisional dissociation fragmentation cell was performed at normalized collision energy of 31 eV. The ion selection threshold was set to 17 000 counts. Selected sequenced ions were dynamically excluded for 60 seconds.
Tissue Samples and Immunohistochemical Methods
Five-micrometer sections of formalin fixed, paraffin-embedded abdominal aortic wall, thrombus, aortic punch, internal mammary arteries, and carotid atherectomies (from 2 patients for each tissue type), undergoing either operation for AAAs, coronary bypass, or carotid atherectomies were obtained from Odense Artery Biobank. All sections were deparaffinized, rehydrated, and demasked by heating sections in TEG (DAKO) for 20 minutes, endogenous peroxidase was blocked by incubation with 3% H 2 O 2 in tris-buffered saline, followed by incubation with 5% skim milk, and then incubated overnight with PRDX1 (Abcam95538, 1:500), Erp72 (ab1903448, 1:100), SERPINA1 (HPA001292 [Sigma-Aldrich], 1:100), XRCC6 (HPA062226 [Sigma-Aldrich], 1:50), Afamin (HPA017006 [SigmaAldrich], 1:300), or appropriate IgG negative control in the same concentration as the primary antibody. The following day after several washes in tris-buffered saline, sections were incubated with horseradish peroxidase-conjugated secondary anti-rabbit (Dako, 1:1000) or for Afamin and XRCC6 EnVision polymer systems horseradish peroxidase-conjugated anti-rabbit (Dako, K4002) and positive staining was visualized with 3,3′-diaminobenzidine (DAKO) and counterstained with Mayers hematoxylin. Representative micrographs were captured using Olympus BX51 microscope with Olympus DP50 camera and CellSens software. Full frame pictures were slightly adjusted for brightness and contrast in photoshop version 9 for optimal readability.
Data Analysis
All Q-Exactive raw data files were processed and quantified using Proteome Discoverer version 2.1.0.81 (Thermo Scientific) for the discovery experiment and version 1.4 for the validation experiment. The Sequest search engine and Mascot search Engine (v. 2.2.3) both integrated with Proteome Discoverer software were used to search the data with the following criteria-protein database: Uniprot/ Swissprot (downloaded November 7, 2012, 452 768 entries) and restricted to humans. Fixed search parameters included trypsin, one missed cleavage allowed, carbamidomethylation at cysteines, and tandem mass tag labeling at lysine and N-terminal amines in case of the discovery experiment. Methionine oxidation and deamidation were set as dynamic. Precursor mass tolerance was set to 8 PPM, and fragment mass tolerance was set to 0.05 Da. Peptide data were extracted using a Mascot significance threshold of 0.05 and a minimum peptide length of 6. A minimum of 2 peptides were used for protein identification and for protein quantification for the tandem mass tag experiment, whereas the area under the curve for the 3 most intense peptides were used for protein quantification in the validation experiment using the precursor ion area detector node in Proteome Discoverer (PD) 1.4. False discovery rate was calculated using a decoy database search, and only high-confidence peptide identifications (false discovery rate <1%) were included.
Identified proteins were divided into 3 groups: plasma proteins, ECM proteins, and cytoskeletal and filament proteins, defined on the basis of existing knowledge about abundance of proteins in human plasma, and matrix and vascular biology.
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Statistical Methods
Growth rate was estimated using individual linear regression. The resulting variable expressing the growth rate was slightly rightskewed and was analyzed with Spearman rank correlation when examining protein ratios and growth rate. The partial Spearman rank correlations were adjusted for smoking and diabetes mellitus status and intervention-size. Fisher exact test was used to test whether the distribution of significant versus nonsignificant correlated plasma-, ECM-and cytoskeletal-proteins were random, as previously described in Preil et al. 22, 23 Statistics were performed using Microsoft Excel, STATA 13. 
Results
Among the electively operated patients where proteome analysis was performed, it was only possible to obtain growth rates for the aneurysm in 24 out of 46 cases. Quantitative proteome results for all 46 samples can be found in Table II The values are given as mean±SD if data are normally distributed; otherwise, median±IQR is given. Percentages are given for the binary characteristics. The 24 individuals who had wall and thrombus samples and corresponding calculated growth rate were divided into 2 groups: wall and thrombus. The clinical demographics were calculated for each group even though 9 individuals had both wall and thrombus samples. AAA indicates abdominal aortic aneurysm; AMI, acute myocardial infarction; ASA, acetylic salicylic acid; COPD, chronic obstructive pulmonary disease; CT, computed tomography; IQR, interquartile range; and PAD, peripheral arterial disease.
*Growth rate is estimated by individual linear regression of ultrasound. Negative correlation 274 39
The 33 wall and thrombus samples from the 24 abdominal aortic aneurysm (AAA) cases are separated into findings from wall and thrombus samples. Only proteins identified in 70% of the samples have been included for analysis (the row directly below the sample number). Absolute numbers (n) of identified proteins are divided into plasma, extracellular matrix, and cytoskeletal proteins and displayed in either the wall or thrombus sample column. The proteins identified from the 33 samples are then correlated with growth rate using Spearman rank correlation and the divided into the 4 bottom squares whether the correlation is significantly negative or positive and whether the protein was identified in the wall or the thrombus samples. The numbers of the proteins are then added up as absolute numbers into the bottom section of the table. ILT] ) ratio of the amounts of all identified collagens and 8 thrombus-related proteins in 9 patients with combined samples of wall and thrombus. The mean ratio (wall/thrombus) of the concentration of all identified 18 collagens (prototype vessel wall proteins; filled squares), and 9 typical thrombocyte-or coagulation-proteins (filled circles) is shown for the 9 patients, where samples of both tissue types were available. The protein identities, the exact ratios, and P values are calculated from Table II in the online-only Data  Supplement and shown in Table IV in the online-only Data Supplement. online-only Data Supplement. From the samples with information about growth rates (estimated by ultrasound), tissue samples from an intact wall were available from 22 patients, and from 11 cases intact thrombus was available. Nine patients had with results concerning growth rates provided both intact wall and thrombus samples, whereas in 13 cases with information about growth, only wall material could be collected and in 2 cases only ILT could be obtained (Figure 1 ). Clinical data from the 2 groups of patients, where associations between proteins and AAA-growth rates in either the ILT or AAA samples could be established, are shown in Table 1 . The median growth rate was 3.8 mm/y (interquartile range, 3.3) and 3.7 mm/y (interquartile range, 2.7), respectively. As expected, mean (SD) AAA size at the time of intervention was close to the size indicative for operation in both groups, that is, 56.4 (5.8) mm (wall group) and 53.1 (4.4) mm, respectively (ILT group; Table 1 ). The proportion of diabetes mellitus was 9.1% and 18.2% in the 2 groups, respectively. Active smokers were slightly more present in the wall group with 27.3% and 18.2% in the thrombus group. Overall, around 87% were males. Statin and aspirin users constituted >90% in both groups. The mean observation time was 3.2 years (SD=1.7) and 3.3 years (SD=1.7), respectively. Hypertension, age, sex, and smoking did not significantly influence growth rates in this population (data not shown).
In the wall and thrombus samples, we identified 750 and 482 proteins, respectively, considering only proteins which were observed in >70% of samples (Table 2; Table II in the onlineonly Data Supplement). Because all samples were calibrated to the same internal standard, we could compare average levels of identified proteins between the 2 sample types. To test the quality of the sampling of the 2 specimen types, we compared the quantity of individual proteins from a group of typical arterial wall protein components, that is, all identified 18 collagen types (identifications of these collagens can be found in Table IV in the online-only Data Supplement), between wall samples and thrombus samples in the 9 patients where samples from both thrombus and wall was available, using paired statistics. The result revealed that although all 18 identified collagens could be detected in both wall and thrombus samples, the collagen concentrations were much higher (2-9 fold) in the wall samples than in the thrombus material (Figure 2 ; Table IV in the onlineonly Data Supplement). Likewise, but opposite, a group of typical coagulation-and thrombocyte-related proteins (identities can be seen in Table IV in the online-only Data Supplement) displayed much lower concentrations (ratios 0.35-0.65) in the wall material than in the thrombus (Figure 2 ; Table IV in the online-only Data Supplement). In the wall samples, 88, 59, and 33 of the identified proteins could be categorized as classical plasma proteins, 19 cytoskeletal proteins, 20 and ECM proteins, 21 respectively as shown in Table 2 . Likewise, among the thrombus samples 77, 37, and 24 were categorized as plasma proteins, ECM, and cytoskeletal proteins, respectively. When using a cut-off of P<0.05 (Spearman correlation), we found within the wall samples, that 323 proteins correlated significantly with the AAA-growth rate, of which 49 showed a positive (Table 3 ) and 274 a negative correlation (the top 50 are shown in Table 4 , and the remaining can be found in Table  I in the online-only Data Supplement). Among individuals with thrombus samples available, 10 proteins correlated positively and 39 negatively with AAA-growth rates (Table 5) . For most proteins, the correlation coefficients and P values did not change much, when the results were adjusted for the influence of diabetes mellitus and smoking status and intervention-size, sex, and age, as can be seen in the tables. As can be seen in the Figure IA and IB in the online-only Data Supplement, the proteins which correlate positive with growth rate, correlate strongly (positive) to each other. Similarly, proteins that correlate negative with growth rate also correlate positive with each other. This is obvious for the wall samples, whereas it is less clear in the thrombus samples, maybe because of a lower number. We could not identify proteins, which independently of others correlate The assignment is given by the number 1 in the table. Only the 49 significant positive correlations (sorted by P value) between relative protein abundance and growth rate from the wall samples are shown here. Both Spearman rank correlation and Spearman partial rank correlation are given with corresponding P values. The partial rank correlations are adjusted for diabetes mellitus and smoking status, intervention-size, and age and sex. Number of proteins show the number of samples, where this protein could be detected and quantitated by the LC-MS/MS method. AAA indicates abdominal aortic aneurysm; and LC-MS/MS, liquid chromatography tandemmass spectrometry.
All proteins have been assigned to either *plasma proteins, †extracellular matrix proteins, ‡cytoskeletal and filament proteins, or none of the mentioned (empty cell). to growth. To verify and validate the quantitative results for a subset of proteins, we reanalyzed all samples with a label-free LC-MS/MS protocol, as described in the Method section. A selected subset of the proteins with high positive correlation to AAA-growth rates in the wall samples could be identified and quantitatively validated because 4 of 7 selected proteins showed significant positive correlations, and 3 showed clear trends, as can be seen in Table III in the online-only Data Supplement. Table 6 displays the distribution of significantly correlated proteins (positive and negative) in both wall and thrombus samples of the 3 investigated classes of proteins (plasma, ECM, and cytoskeletal proteins). Among the aneurysmatic wall samples, a total of 88 plasma proteins were identified and 35 of these displayed positive significant correlations with aneurysmatic growth rates, which is a large majority of the total of 49 positive significant proteins. Inversely, only 1 plasma protein showed negative correlation with growth rates (out of 274 significant proteins). This result is highly unlikely to occur by chance (P<0.001, Fisher exact test). As seen in Table 6 , we also identified 59 ECM proteins and 33 cytoskeletal molecules in the wall samples. No altered distribution of these molecules was observed after classifying matrix and cytoskeletal proteins according to positive correlations, but a significant higher with negative correlations to growth rates were observed among the ECM proteins. In a similar fashion, we also observed that plasma proteins in the thrombus were more abundant among the group of proteins that correlated with growth (Table 6 ; P<0.001, Fisher exact test); however, the number of cytoskeletal proteins with significant correlations to growth rates were randomly distributed. As in the wall samples, the ECM proteins in the thrombus were significantly more abundant among the group of proteins that correlated with negative growth. In addition, we performed network/ pathway analysis for positively and negatively correlated proteins in both thrombus and wall samples. As can be seen in the Figures VII through X in the online-only Data Supplement plasma proteins related to both the complement cascade, lipoproteins, protease inhibition, and immune response was identified in the positive correlated in wall and thrombus, whereas for example proteins present in the endoplasmatic reticulum and related to protein folding was identified among negatively correlated in the wall and ECM proteins in the thrombus (Figures VII through X in the online-only Data Supplement).
The correlations between AAA growth and the expression levels of the 4 most significant positively associated proteins in the wall samples were as follows; Ig-γ-3 chain C region, CD5 antigen-like, complement C3, and ITIH4 (interalpha-trypsin inhibitor heavy chain H4) protein. These are shown in Figure 3A through 3D. The 4 most negatively associated nonplasma proteins in the wall samples were as follows; 60s ribosomal protein L4, 60 ribosomal protein L9, collagen α-1(X) chain, and X-ray repair cross-complementing protein 6, as presented in Figure 4A through 4D.
Unfortunately, it is not doable to visualize the location of all identified proteins in the arterial and thrombus tissue; however, to explore the location of some of the relevant proteins, it has been possible to perform immunohistochemical staining on 5 proteins, as shown in Figures II through VI in the online-only Data Supplement. Two visualized proteins showed high positive correlation with growth rate (α-1-antitrypsin and afamin) in wall samples, and 3 show high negative correlations to growth rates (protein disulfide-isomerase A4, X-ray repair cross-completing protein 6, and peroxiredoxin-1). The visualizations of the 2 abundant plasma proteins α-1-antitrypsin and afamin gives a diffuse staining of both wall and thrombus but is only seen in small amounts in normal arterial material. In addition, the 3 examples of negative correlated proteins display cellular The assignment is given by the number 1 in the table. Only the 50 most significant negative correlations (sorted after P value) between relative protein abundance and growth rate from the wall samples are shown here. The remaining 224 proteins with significant negative correlation are presented in Table I in the online-only Data Supplement. Both Spearman rank correlation and Spearman partial rank correlation are given the table with their corresponding P values. The partial rank correlations are adjusted for diabetes mellitus and smoking status, intervention-size, age, and sex. Number of proteins show the number of samples, where this protein could be detected and quantitated by the LC-MS/MS method. AAA indicates abdominal aortic aneurysm; and LC-MS/MS, liquid chromatography tandem-mass spectrometry.
All proteins have been assigned to either *plasma proteins, †extracellular matrix proteins, ‡cytoskeletal and filament proteins, or none of the mentioned (empty cell). 
Discussion
In this proteome study of individual aneurysmatic wall and thrombus specimens from 24 patients who underwent elective AAA repair, the overall results show that high tissue content of plasma proteins is associated with high preoperative growth rates, whereas high wall and thrombus concentrations of particular vascular cell proteins are found in AAAs with low growth. Only a few published studies have previously performed proteome analysis on material from human AAAs.
12-
15,24-27 Our investigation differs from these studies not only by the use of a considerably higher number of patients but also by the separation of tissue samples into thrombus and wall material. We observed a significant difference in the protein composition of these 2 sample types, which demonstrates the quality of our sampling and clearly shows that it is important to make this division to avoid that results mostly reflect the ratio of thrombus/wall material in the analyzed samples. Only 1 previous study 12 has attempted to correlate the expansion rates with protein quantities, but only 6 samples were used, and no separation of thrombus and wall material was done. We found no overlap between the results from the 9 identified proteins in that study and the present outcomes.
Among the >700 quantitated proteins in both thrombus and wall material, many correlated with growth rate. The clearest result is that the tissue concentrations of a highly significant number of plasma proteins correlate positively with the aneurysmatic growth rate, that is, when the growth rate of the aneurysm was high in the period before the operation, the concentrations of many plasma proteins were high in the obtained sample. This phenomenon was observed in both wall and thrombus samples; and the finding fits very well into the theory of centrifugal transport of plasma peptides through the ILT and the AAA wall as previously hypothesized. 5 This idea of centrifugal transport is based on studies 5, 6 showing that canniculi in the ILT and perhaps also the aneurysmatic tissue itself are present and they are believed to convey cells, proteins, and fragmented peptides toward and through the AAA wall, possibly resulting in harmful effects. 5 Larger cells like macrophages are more likely to be present in the luminal layers, 6 but can also be found in deeper layers. Another study showed that the canniculi were larger in the abluminal part of the ILT than in the luminal part, 11 which could make it easier for both larger molecules and even cells to reach the AAA wall. The findings in our study support the hypothesis of the leaky ILT and spongy vessel wall that may allow proteases and other unfavorable molecules to build up and degrade wall components ultimately leading to AAA growth. As the study design prohibits continuous sampling of AAA wall and ILT some of the proteins identified may have been synthesized within the tissue. Looking at results of another of the predefined groups of proteins in our study, that is, ECM proteins, we found a significant high number of matrix proteins that were negatively correlated with growth rate in the wall and in the thrombus. It may be speculated that a high concentration of matrix molecules in the wall contributes to the possibly mechanically protective 28 attributes, which we observe as a slower growth rate in the present study. Matrix molecules in the thrombus may be a sign of a stable or more organized thrombus that may be more rigid or less permeable and thus more protective. This is speculative, but ILT may have different phases as has been proposed 4 although evidence for this concept is not clear. The idea that the ILT has several life phases could mean that it could be theoretically susceptible to different medicine that either strengthens the thrombus or inhibits the deposition. Furthermore, a few matrix proteins of interest showed significant correlations and might play protective roles. This may be the case for EMILIN-1 (Elastin microfibril interface-located protein 1), which before this present study has also The assignment is given by the number 1 in the table. Only the 10 significant positive and 39 significant negative correlations between relative protein abundance and growth rate from the thrombus samples are shown here. The top section covers the positive correlations, and the bottom section covers the negative correlations. Both Spearman rank correlation and Spearman partial rank correlation are given the table with their corresponding P values. The partial rank correlations are adjusted for smoking and diabetes mellitus status, intervention-size, age, and sex. Number of proteins show the number of samples, where this protein could be detected and quantitated by the LC-MS/MS method. AAA indicates abdominal aortic aneurysm; and LC-MS/MS, liquid chromatography tandem-mass spectrometry.
All proteins have been assigned to either *plasma proteins, †extracellular matrix proteins, ‡cytoskeletal and filament proteins, or none of the mentioned (empty cell). 29 and which is associated with the formation of elastic fibers. In line with this, patients with thoracic dissections had downregulated EMILIN-1, 30 possibly indicating that EMILIN-1 is important for intact elastic tissue.
Whereas most of the wall proteins which display a positive correlation between concentration and growth rate are plasma proteins as discussed above, the composition of the group of proteins with negative correlations with growth in the wall samples is completely different. Notably, many cytoskeletal proteins are negatively correlated with growth rates (Table 6 ). This group of proteins is large and represents for the most abundant intracellular proteins from vascular smooth muscle cells. It is likely that some of the present of these cells and proteins is related to protection against aneurismal growth, although causation cannot be deducted from our observations. It is also remarkable that many molecules in this group of proteins with high tissue concentrations in aneurysms with low growth are related to protein synthesis, that is, 40S ribosomal protein S4, 40S ribosomal protein S19, and other ribosomal proteins, as well as elongation factor 2. It is also interesting to note that the presence of enzymes related to the posttranslational processing of collagens, that is, peptidyl-prolyl cis-trans isomerase and protein disulfide-isomerase A4 correlates negatively with growth rates. Likewise, several enzymes related to the production of energy and related to cellular metabolism are also present, that is, mitochondrial citrate synthase and cytochrome c oxidase subunit 7A2. The presence of these proteins and their negative relation to growth is compatible with the idea that the presence of many active vascular cells in the aneurysmatic wall may protect against expansion.
In this present study, we identified peroxiredoxin-1 in the AAA-wall samples to be significantly negatively correlated with AAA-growth rate (Spearman ρ=−0.77, P>0.001). This may be a response to oxidative stress, which may be important The tables display the numbers of identified proteins from the abdominal aortic aneurysm (AAA) wall and thrombus samples in the top 6 and bottom 6 tables, respectively. The tables are presented for each protein family and separated into results concerning positive and negative Spearman rank correlations (r). Within each table, the distribution of the protein type of interest is grouped according to significant and nonsignificant Spearman rank correlation and compared with all other proteins and significance of the null hypothesis (random distribution) is calculated with Fisher exact test. For example, the top left 2×2 table shows that there are significantly more plasma proteins in the wall samples among the significant positively correlated proteins compared with the nonsignificant positively correlated proteins. The tables with a significant Fisher exact test are highlighted in bold writing. Cytoskel. indicates cytoskeletal; and ECM, extracellular matrix. *Significant Fisher exact test.
in the pathogenesis of AAA. 25, 31 Interestingly, in a previous study of 10 patients, peroxiredoxin-1 was found to be increased in the luminal compared with the abluminal part of the ILT. 24 The abundant erythrocytes in the luminal part of the ILT deliver an endless supply of cells that generate reactive oxidative species. 32 Several molecular countermeasures are known to act as defense mechanisms against oxidative stress. In the wall samples, we found both thioredoxin and thioredoxin domain-containing protein, which are defenders against oxidative stress, to be significantly negatively correlated with growth rate, which is compatible with the idea that upregulated defense against reactive oxygen species may slower the growth rate. The findings of thioredoxin are in line with those reported in a previous study that identified thioredoxin at the luminal part of the AAA and described its potential role in AAA evolution. 33 A series of proteins of potential interest both in relation to pathophysiology and as biomarkers can be found in the present results. The complex glycosylated glycoprotein afamin was one of the most positively correlated with growth rate. Afamin resembles albumin and has capabilities as a plasma-carrier of vitamin E. It has not been studied in relation to AAA, but may be associated with metabolic syndrome and hyperglycemia, 34 a condition related to vascular disease. 35 A case of an iliac aneurysm in a child with Menkes syndrome has been described. Menkes disease is a disease with a low concentration of ceruloplasmin, which may be of interest to the present results, where we observe that this protein related to AAA growth. 36 Ceruloplasmin is also related to the regulation of the oxidation state of iron and other molecules, linked to inflammation, which may be involved in the development of aneurysms. 37 Likewise, other proteins positively related to growth, like immunoglobulins and eosinophil peroxidase may be related to inflammation.
In conclusion, aneurysms with a high growth rate contain high concentrations of many plasma proteins in both the ILT and the aneurysmatic wall itself at the time of the operation. This finding is compatible with the idea that a high porosity of the thrombus and the damaged wall is associated with high expansion rates, possibly because of the accumulation of harmful active peptides, degrading arterial tissue, and increasing expansion. However, the presence of increased amounts of several ECM and cytoskeletal proteins in the wall is negatively associated with growth rate, and the same is true for a long series of proteins involved in cellular protein synthesis, energy production, and protection against reactive oxygen species. This is in line with the notion that high cellular and fibrotic activity may be beneficial, and it can be speculated that targeted medical approaches to stimulate these functions may slow down the growth rate. In addition to providing molecular pathological and pathophysiological insights into aneurysm biology, the proteins identified in our study provide a list of putative new potential markers and treatment targets for AAA.
